AzTrials
AzTrials

Mechanical VentilationNCT03118804

Weaning From Mechanical Ventilation Guide by Assessment of Lung Tidal Distribution With EIT

An observational study of Mechanical Ventilation, run by Southeast University, China at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To evaluate whether EELI, RVD, GI were good predictor for weaning from mechanical ventilation Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Mechanical Ventilation
What is being tested?
Assessment of Lung Tidal Distribution With EIT
How many people
55 participants
Where
1 siteChina
Study dates
18 Oct 2016to 31 Dec 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients with mechanical ventilation admitted to ICU of Zhongda hospital

Who may be able to join

  • Intubated patients age between 18 years old and 80 years old
  • Duration of controlled mechanical ventilation≥ 24 h
  • Patients ready to wean from mechanical ventilation
  • Informed consent

Who cannot join

  • Pregnant women
  • Patients with malignant tumor
  • High paraplegia, neuromuscular lesions
  • Thoracic deformity, diaphragmatic hernia
  • Patients with ECMO
  • Patient participated in another interventional trial before enrollment

Trial locations and contacts

1 site in 1 country.

China1 site
  • Zhongda Hospital

    Nanjing, Jiangsu

Other trials in China

About this study

To evaluate whether EELI, RVD, GI were good predictor for weaning from mechanical ventilation

Read the detailed description

53 patients who ready to wean from mechanical ventilation were included in this study. The changes of lung tidal distribution during SBT with mechanical ventilation by EIT were recorded. Whether EELI, RVD, GI were good predictor for weaning from mechanical ventilation?

Being tested
Assessment of Lung Tidal Distribution With EIT
Keywords
Weaning, Mechanical ventilation, Electrical impedance tomography, Tidal distribution

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Assessment of Lung Tidal Distribution With EITDiagnostic test

    Changes of lung tidal distribution during SBT with mechanical ventilation were recorded by EIT can be used to predict weaning success or failure

Study groups in NCT03118804
Study groupRoleWhat they receive
Weaning Guide by EITWeaning From Mechanical Ventilation Guide by Assessment of Lung Tidal Distribution With EIT
Receives: Diagnostic Test: Assessment of Lung Tidal Distribution With EIT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Weaning duration

    Time of weaning duration from SBT to weaning from mechanical ventilation

    Measured: 48 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Apr 2017
  2. Study start18 Oct 2016
  3. Primary completion31 Dec 2018
  4. Study completion31 Dec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
55 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03118804
Sponsor's protocol ID
2016ZDSYLL064-Y01
Status last verified
Nov 2022
First submitted
9 Apr 2017
Last updated
30 Nov 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Mechanical Ventilation, run by Southeast University, China at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Weaning duration (time frame: 48 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in